HNRNPA1 and cancer: However, subset analyses revealed that hnRNPA1 overexpression was associated with 9 of 11 deletions in ERG-negative cancers (p < 0.05) and with 6 of 11 deletions in ERG-positive cancers (p < 0.05, Supplementary Fig. 2).